HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter Sillevis Smitt Selected Research
Peter Sillevis Smitt Research Topics
Disease
3
Neoplasms (Cancer)
01/2021 - 05/2015
3
Paraneoplastic Cerebellar Degeneration
06/2012 - 06/2003
2
Hodgkin Disease (Hodgkin's Disease)
06/2012 - 05/2010
2
Cerebellar Ataxia (Dysmetria)
05/2010 - 06/2003
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1
Cerebellar Diseases (Cerebellar Syndrome)
12/2020
1
Encephalitis (Encephalitis, Rasmussen)
12/2020
1
Neurologic Manifestations (Neurological Manifestations)
12/2020
1
Dementia (Dementias)
12/2015
1
Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
12/2015
1
Autoimmune Diseases of the Nervous System
12/2015
1
Ataxia (Dyssynergia)
05/2010
1
Autoimmune Diseases (Autoimmune Disease)
05/2010
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2006
Drug/Important Bio-Agent (IBA)
5
Antibodies
IBA
01/2021 - 06/2003
2
metabotropic glutamate receptor type 1
IBA
12/2020 - 05/2010
2
Antigens
IBA
12/2015 - 06/2012
2
Autoantibodies
IBA
06/2012 - 05/2010
1
N 30
IBA
12/2020
1
Immunoglobulin G (IgG)
IBA
12/2020
1
Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)
IBA
12/2020
1
Tyrosine Kinase Inhibitors
IBA
06/2020
1
ErbB Receptors (EGF Receptor)
IBA
05/2015
1
Epidermal Growth Factor (EGF)
IBA
06/2012
1
Rituximab (Mabthera)
FDA Link
01/2006
1
Monoclonal Antibodies
IBA
01/2006
Therapy/Procedure
1
Therapeutics
05/2010